| 11324743 |
Treatment for the non alcoholic steatohepatitis and fibrosis |
Gabriel Baverel |
2022-05-10 |
|
| 9545387 |
Composition and kit comprising piperazine derivatives and metformin, and use thereof in the treatment of diabetes |
Gabriel Baverel |
2017-01-17 |
|
| 9150529 |
Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance |
Gabriel Baverel, Remi Nazaret, Bernard Ferrier |
2015-10-06 |
|
| 9150523 |
Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance |
Gabriel Baverel, Remi Nazaret, Bernard Ferrier |
2015-10-06 |
|
| 9120805 |
Substituted pyrrolo[1,2-A]pyrazin-1-ones and pyrazolo[1,5-A]pyrazin-4-ones as inhibitors of tankyrase and poly(ADP-ribose)polymerase activity |
Dieter Dorsch, Hans-Peter Buchstaller, Ansgar Wegener |
2015-09-01 |
$63,976,000 |
| 8791115 |
Combination of triazine derivatives and insulin sensitisers |
Daniel Cravo, Didier Mesangeau |
2014-07-29 |
|
| 8673955 |
Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
Denis Carniato, Gerard Botton, Annick Arbellot De Vacqueur, Annick Audet |
2014-03-18 |
$46,244,000 |
| 8362057 |
Imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
Gerard Botton, Annick Arbellot De Vacqueur |
2013-01-29 |
$43,785,000 |
| 8329738 |
Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
Dominique Marais, Sophie Hallakou-Bozec, Christine Charon |
2012-12-11 |
$46,772,000 |
| 8227465 |
Combination of triazine derivatives and insulin secretion stimulators |
Daniel Cravo, Didier Mesangeau |
2012-07-24 |
|
| 8217040 |
Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
Daniel Cravo |
2012-07-10 |
|
| 7897644 |
Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
Dominique Marais, Philippe Maizeray |
2011-03-01 |
$144,695,000 |
| 7816397 |
Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
Gerard Botton, Micheline Kergoat |
2010-10-19 |
$75,824,000 |
| 7767676 |
Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
Daniel Cravo, Liliane Doare, Micheline Kergoat, Didier Mesangeau |
2010-08-03 |
|
| 7727977 |
Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
Valerie Autier, Annick Arbellot De Vacqueur, Dominique Mariais, Catherine Kargar, Micheline Kergoat |
2010-06-01 |
$58,352,000 |
| 7501511 |
Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome |
Daniel Cravo, Thierry Passemar |
2009-03-10 |
$208,930,000 |
| 7491733 |
Bicyclic guanidine derivatives and therapeutic uses thereof |
Daniel Cravo |
2009-02-17 |
$70,718,000 |
| 7470708 |
Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
Jean-Claude Correc, Annick Arbellot De Vacueur |
2008-12-30 |
$77,197,000 |
| 7452883 |
Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
Daniel Cravo, Liliane Doare, Micheline Kergoat, Didier Mesangeau |
2008-11-18 |
|
| 7375130 |
Antidiabetic compounds comprising benzofuran and benzothiophene derivatives |
Caroline Leriche, Micheline Kergoat |
2008-05-20 |
$121,386,000 |
| 7371774 |
Benzofurans and benzothiophenes |
Caroline Leriche, Micheline Kergoat |
2008-05-13 |
$50,118,000 |
| 7285681 |
Biguanide derivatives |
Daniel Cravo |
2007-10-23 |
$116,164,000 |
| 7034021 |
Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
Daniel Cravo, Liliane Doare, Micheline Kergoat, Didier Mesangeau |
2006-04-25 |
|
| 6518458 |
(Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy |
Daniel Cravo, Didier Mesangeau, Liliane Doare, Micheline Kergoat |
2003-02-11 |
$137,318,000 |
| 6437143 |
Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
Gerard Botton, Etienne Prugnard, Liliane Doare, Micheline Kergoat, Didier Mesangeau |
2002-08-20 |
$94,371,000 |
